BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CPRT
Copart, Inc.
CPRT has the edge over BA overall, supported by stronger valuation and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
CPRT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
CPRT's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over CPRT in the historical PE scenario, which offers more potential upside but is not a forecast.
CPRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $32.00 | — |
| Current | 21x | $32.00 | — |
| Cheap | 24x | $37.74 | +18% |
| Fair | 34x | $53.05 | +66% |
| Expensive | 39x | $60.99 | +91% |
Historical ranges are pointers, not guarantees.
CPRT's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over CPRT on the outlook, with more favorable profitability expectations.
CPRT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CPRT, but weaker profitability.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
CPRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | +7% |
| Q3 2026 | $1.55 | -2.5% |
| Q2 2026 | $1.60 | +4.6% |
| Q1 2026 | $1.59 | +6% |
| Q4 2025 | $1.63 | +14% |
| Q3 2025 | $1.59 | +14% |
| Q2 2025 | $1.53 | +7.7% |
| Q1 2025 | $1.50 | +7.9% |
| Q4 2024 | $1.43 | +5.1% |
CPRT has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over CPRT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
CPRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +2.4% |
| Q2 2026 | $1.2B | +2.1% |
| Q1 2026 | $1.1B | -3.6% |
| Q4 2025 | $1.2B | +0.7% |
| Q3 2025 | $1.1B | +5.2% |
| Q2 2025 | $1.2B | +7.5% |
| Q1 2025 | $1.2B | +14% |
| Q4 2024 | $1.1B | +12% |
CPRT's revenue grew through 2024 and has held roughly level since: $1.2B last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -4.7 points |
| Q2 2026 | 38% | +0.3 points |
| Q1 2026 | 35% | -2 points |
| Q4 2025 | 37% | +1.9 points |
| Q3 2025 | 37% | +3 points |
| Q2 2025 | 37% | -1.5 points |
| Q1 2025 | 37% | -0.6 points |
| Q4 2024 | 35% | -3.3 points |
CPRT has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over CPRT on cash flow, with more consistent year-over-year improvement.
CPRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $278.7M | -21% |
| Q2 2026 | $503.3M | -20% |
| Q1 2026 | $57.9M | +1330% |
| Q4 2025 | $427.2M | +74% |
| Q3 2025 | $350.8M | +16% |
| Q2 2025 | $630.4M | +54% |
| Q1 2025 | $4M | -90% |
| Q4 2024 | $245.5M | +15% |
CPRT generated $1.3B in free cash flow over the past year, up 3% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
CPRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -1.8x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -2.7x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.1x | Net Cash |
CPRT has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
CPRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.4 | Neutral |
| Stochastic | 63.3 | Neutral |
CPRT's weekly RSI is 53 (neutral) and its Stochastic is 63 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over CPRT on valuation relative to its sector.
CPRT PE vs Industrials Sector
| Metric | CPRT | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 24x | 14% below |
| PE % | 7 | 58 | 51 pts below |
CPRT is trading at 21x earnings, a 14% discount to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
CPRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.9% above |
| 20 week MA | $29.8 | 7.3% above |
| 50 week MA | $33.3 | 3.8% below |
| 100 week MA | $42.3 | 24% below |
| 200 week MA | $45.1 | 29% below |
CPRT has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
CPRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $30.9 | +36% |
| 2021 | $30.9 | $36.5 | +18% |
| 2022 | $36.5 | $30.3 | -17% |
| 2023 | $30.3 | $49.0 | +62% |
| 2024 | $49.0 | $58.5 | +19% |
| 2025 | $58.5 | $39.3 | -33% |
| 2026 YTD | $39.3 | $32.0 | -19% |
CPRT has the edge over BA on returns for 2026, with the stronger performance.